SoFi’s 40% Revenue Surge Masks an Unfinished Tech-Platform Recovery

What happened

SoFi’s Q2 2026 adjusted net revenue jumped 40% year over year to $1.206 billion, with EPS up 50%, as cross-sell delivered two new products for every new member, reaching 15.8 million members and 24.4 million products. Management raised full-year revenue guidance to $4.75–$4.85 billion, but left EBITDA guidance unchanged at about $1.6 billion, signaling that incremental revenue is not yet converting into margin. The Technology Platform segment remains the critical bottleneck, still down 23% year over year at $84.5 million in revenue despite a 13% sequential improvement from Q1 and a rebound in enabled accounts to 134.8 million. Deposit-funded lending continues to anchor earnings with a 156‑basis‑point funding‑cost advantage and a 5.98% net interest margin, while strong credit metrics and open loan‑sale markets support origination growth. The stock, at $16.50 and 32x trailing earnings, now reflects a partial recovery but still demands evidence that non‑lending profit streams can scale before the next credit cycle wobble.

Implication

The Q2 results solidify the base case of deposit‑funded lending and cross‑sell compounding, yet the unchanged EBITDA guidance and the 23% Tech Platform decline remind investors that diversification is still a promise, not a reality. A single quarter of sequential tech recovery is insufficient; the next report must deliver positive YoY platform revenue and stabilizing Financial Services margins to support a re‑rating above $20. Credit quality remains pristine with 90‑day delinquencies at 40 bps, but any uptick in consumer stress would disproportionately hit the high‑multiple stock. The margin of safety is operational rather than valuation‑based, so position sizing should be cautious, adding only on dips toward $15 with a strict trim above $21. We watch the 90‑day checkpoints: platform growth, margin improvement, and credit trends will dictate whether the thesis strengthens or breaks.

Thesis delta

The Q2 results reinforce the base‑case scenario with record originations, raised revenue guidance, and robust cross‑sell, but the unchanged EBITDA guide and persistent Tech Platform weakness prevent an upgrade to a full‑conviction buy. We maintain our POTENTIAL BUY rating with conviction 4.0, attractive entry below $15, and trim above $21, demanding another quarter of confirmation for the non‑lending recovery.